Anzeige
Mehr »
Login
Sonntag, 19.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
GOLD-MINEN vor Jahrhundert-Hausse?! Diese Aktie sofort kaufen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
62 Leser
Artikel bewerten:
(0)

Research and Markets - Global Breast Biopsy Market to Grow at a CAGR of 10.7%, 2017-2021 with BD, C.R. Bard, Hologic & Leica Biosystems Leading the Way

DUBLIN, Apr. 05, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Breast Biopsy Market 2017-2021" report to their offering.

Research and Markets Logo

The global breast biopsy market to grow at a CAGR of 10.70% during the period 2017-2021.

The report, Global Breast Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is increase in reimbursement for breast biopsy. The rise in the number of breast biopsy procedures in the last few years has seen a corresponding increase in reimbursement for breast biopsies. Most of the medical healthcare facilities such as the Centers for Medicare & Medicaid Services (CMS) had fixed payment for bundled breast biopsy devices in 2015. This has leveraged the reimbursement to hospitals by 51% compared with 2014 rates.

According to the report, one of the major drivers for this market is growing incidence of breast cancer. The rising incidence of breast cancer is fueling the growth of the breast biopsy market worldwide. Breast cancer is the most common cancer prevalent in females and is the second most common cancer overall, after skin cancer. Breast cancer is found to affect men above 50 years of age and is rare in young women.

Key vendors

  • BD
  • C.R. Bard
  • Hologic
  • Leica Biosystems

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

PART 05: Breast cancer: An overview

PART 06: Market landscape

PART 07: Market segmentation by product type

PART 08: Market segmentation by modality

PART 09: Market segmentation by end-user

PART 10: Geographical segmentation

PART 11: Decision framework

PART 12: Drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Key vendor analysis

PART 16: Appendix

For more information about this report visit http://www.researchandmarkets.com/research/x7qjgr/global_breast

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.